using population-based mouse models to explore individual...
TRANSCRIPT
Using Population-based Mouse Models to Explore Individual Variability and Toxicity
John E. (Jef) French, Ph.D.Host Susceptibility Group
N ti l T i l P NIEHSNational Toxicology Program, NIEHSResearch Triangle Park, NC 27709 USA
([email protected])A il 18 2012April 18, 2012
Hazard Identification & CharacterizationE id i l• Epidemiology– Exposure assessment– variability between intensity (peak
exposure), inter- and intra-individual exposures and lti l t i t it d i di itmultiple exposure routes; intensity and periodicity
– Disease endpoints are categorical– Population differences based upon individual variability
through candidate gene and genome wide association analysis (CGAS and GWAS)
• Animal Models of Human Disease– Historical – Use of 1 or 2 inbred strains or outbred stocks
to test specific agents or mixtures representing occupational exposures
– Routes and lengths of exposure (partial or lifetime)– Mechanism of action studies for causality (support Hill’s
postulates)p )• Type 1 and Type 2 errors based upon exposure
misclassification and population architecture
Mouse models for human diseases•Most diseases are heritable quantitative or continuous traits
Mouse models for human diseasesq
•Use population-based models to identify highly variable genotypes-phenotypes associated with a toxicity or disease phenotype ( i t & tibilit )(resistance & susceptibility)
•Functionally validate SNP/SV associations for causal relationships using reverse genetics and in vitro/in vivo targeted testing methodsg g g g
•Anchor extrapolation between species for exposure and disease risk to highly conserved orthologous loci and networks or path a s shared bet een the animal model and h manspathways shared between the animal model and humans
Benzene Metabolism and Toxicity
Rappaport et al. EHP 117, 946 (2009)
P l ti B d M d l f I b d M St i
• Research community resource
Population Based Model of Inbred Mouse Strains
• Proposed for population based model for environmental exposures, toxicity, and diseaseB d NTP/NIEHS P l DNA• Based upon NTP/NIEHS-Perlegen DNA sequencing of 15 inbred strains for comparison to the mouse reference strain – C57BL/6J. B6C3F1 and PWK/LacJ) were included for additional comparisons –
• Total 18 inbred strains• Total 18 inbred strains• Major impact on understanding the mouse
genomeg
Rank order blood [14C] benzene equivalents in males following a single oral exposure (100 g/kg; n=5; μ SE)
B6C3F1DBA/2J
MOLF/EiJNZW/LacJ
A/JBALB/cByJ
BTBR T+tf/JNOD/ShiLtJ
B6C3F1
C3H/HeJAKR/JKK/HlJ
A/J
CAST/EiJPWK/PhJ
129S1/SvImJC57BL/6J
• 10X difference AUC• B6C3F1 > B6 or C3• PWD/PhJ ≤ CAST/EiJ ≤ PWK/PhJ
FVB/NJWSB/EiJ
PWD/PhJPWD/PhJ ≤ CAST/EiJ ≤ PWK/PhJ
0 50000 100000 150000 200000 250000 300000
Blood AUC Males (min*µmol-Eq/ml)
Blood
CopaSox2;Atp11b Rybp
Wdr17Plod2
Bcap29;Tmx1
GmdsEdnrb
Best1
Cdh2;Dsc3
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Rank order blood [14C] benzene equivalents CL_F in males following a single oral exposure (100 g/kg; n=5; μ SE)
BTBR T+ tf/JCAST/EiJ
FVB/NJPWD/PhJ
129S1/S I JKK/HlJAKR/J
C57BL/6JBTBR T+ tf/J
•10X differencesBALB/ B J
C3H/HeJNOD/ShiLtJ
WSB/EiJ129S1/SvImJ
•B6C3F1 < B6 or C3•PWK/PhJ < PWD/PhJ & CAST/EiJ
CDBA/2J
PWK/EiJA/J
BALB/cByJ
PWK/PhJ
0 00 0 50 1 00 1 50
NZW/LacJMOLF/EiJ
B6C3F1
0.00 0.50 1.00 1.50Male Blood CL_F ml/min
Blood
Elf2
Gstm6
Xpa(Mitf;Gm765)
(Otog;Myod1)Tmem45b
Entpd1Slc16a4
Nell1
Tlr5Gstm6
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 171 8 19 20
Blood AUC-CL_F Correlation R2 = 0.59 and p = 0.0003
P di t d Y [ l/ i ]
87000
97000
107000
ol/m
l)
Predicted Y [ml/min]
47000
57000
67000
77000
(min
*nm
17000
27000
37000
0.1 0.3 0.5 0.7 0.9 1.1
AU
C
Blood CL F (ml/min)_ ( )
68000
78000
88000
mol
/ml
Predicted Y [Systolic]
R2 = 0.55p = 0.004
18000
28000
38000
48000
58000
UC
min
*nm p 0.004
84 94 104 114 124 134 144 154 164AU
Systolic BP
Predicted Y [Systolic]
0.8
0.9
1
1.1
1.2
ml/m
inPredicted Y [Systolic]
R2 = 0.16p = 0.16
0.3
0.4
0.5
0.6
0.7
CL_
F m
0.284 104 124 144 164
Systolic BP
Rank order bone marrow AUC [14C] benzene equivalents in males following a single oral exposure (100 g/kg; n = 5; μ SE)
B6C3F1MOLF/EiJPWK/EiJ
following a single oral exposure (100 g/kg; n 5; μ SE)
NOD/ShiLtJPWD/PhJ
KK/HlJNZW/LacJ
B6C3F1
AKR/JDBA/2J
BALB/cByJ129S1/SvImJNOD/ShiLtJ
• 19 fold difference• B6C3F1 > B6 or C3
WSB/EiJA/J
CAST/EiJC57BL/6J
AKR/J • B6C3F1 > B6 or C3• CAST/EiJ - low AUC but > WSB or C3
0 2 4 6 8 10
FVB/NJBTBR T+ tf/J
C3H/HeJWSB/EiJ
0 2 4 6 8 10Male Bone Marrow AUC (min*micromoles/mg protein x103)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 1 8 19 20
R k d b CL F [14C] b i l t l
FVB/NJBTBR_T+_tf/J
Rank order bone marrow CL_F [14C] benzene equivalents clearance rate in males following a single oral exposure (100 g/kg; n=5; μSE)
C57BL/6JA/J
AKR/JC3H/HeJFVB/NJ
CAST/EiJNOD/LtJ
BALB/cByJDBA/2J
C57BL/6J
• 36 fold differences
WSB/EiJPWD/PhJ
KK/HlJ129S1/SvImJ
CAST/EiJ • 36 fold differences• B6C3F1 > B6 or C3• CAST intermediate CL_F phenotype
PWK/PhJMOLF/EiJ
B6C3F1NZW/LacJ
WSB/EiJ
0 10 20 30 40 50 60 70 80 90Male Bone Marrow CL_F (mg protein/min)
All i t i d 5’ t did t
C3: Ints12C15: Tbc1d22a
All intergenic and 5’ to candidate
C9: Vps13c
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 1 8 19 20
Conclusions• ADME/TK studies in a limited panel of 18 inbred strains
demonstrated a 10-36X difference across strains for AUC and CL Fdemonstrated a 10 36X difference across strains for AUC and CL_F in blood and bone marrow
• Model lacked power to achieve genome wide significance and minimize potential false positives candidate genes using haplotype association mapping tools
• The phenome panels of inbred strains of mice (35-40 strains) are difficult to use for genetic/epigenetic analysis due to lack of genetic power and efficiency required to load studies due to breeding andpower and efficiency required to load studies due to breeding and reproductive differences
• Laboratory derived inbred strains are largely identical by descent with limited linkage disequilibrium (LD) networks with pervasive high inter-limited linkage disequilibrium (LD) networks with pervasive high interchromosomal linkage, leading to low accuracy in genetic analysis
• Consequently, new models are required for genetic analysis in order to to demonstrate population based differences for individual variability
The J:DO diversity outbred mouse • A population based model for environmental
exposures, toxicity, and disease• Complex traits community resource• Complex traits community resource• DO mice derived from the Collaborative Cross
(CC) advanced recombinant intercross lines( )
The Collaborative Cross*
Strain Letter Color
The Collaborative Cross(8-way advanced recombinant inbred lines)
Strain Letter ColorA/J A
C57BL/6J B129S1/SvImJ CNOD/ShiLtJ D
NZO/LtJ ECAST/EiJ FPWK/PhJ GWSB/EiJ HWSB/EiJ H
*See suggested references provided for supplementary reading
Collaborative Cross (CC) & Diversity Outbred (J:DO) Models≈45 million segregating SNPs
J:DO mice(CC G4 G5)(CC G4:G5)
4-8 Mb
≥10% minor allele frequency
Benzene 28 Day Inhalation Study at NIEHS/NTP
• 0 1 10 or 100 ppm benzene exposure groups• 0, 1, 10 or 100 ppm benzene exposure groups• 28 days - 6 hr TWA daily at target for each exposure• Diversity outbred (J:DO) male mice (7 & 8th randomlyDiversity outbred (J:DO) male mice (7 & 8 randomly
outbred generation; selected from 175 breeding pairs)• Randomly assigned to exposure group by weight• 75 mice/exposure group × 4 exposure concentrations• 300 male mice /study (600 total with 2 cohorts)
NIH31 di t h d i• NIH31 diet; housed on wire • NTP Specifications (with cited exceptions)
Peripheral Blood %MN-RET
Each mouse is genetically different…Peripheral Blood %MN-RET
DNA Damage
Significant
DNADNA DamageMinimal
Benzene, 100 ppm – Bone Marrow %MN-RET Chr 10 QTL
Whole Genome Plot Chr 10:27-35Mb
QTL segment
129S1/SvlmJ
Coefficient for CAST/EiJ
LOD
allele identity
LOD
Benzene, 100 ppm – Bone Marrow %MN-RET Chr 10 QTLChr 10:27-35Mb
14 43
Chr 10:27 35Mb
67
7
3
5
5
3
Susceptible
7
4
1
66
2 3 5 2 2Susceptible
10 12 26 17
7
Resistant
Resistant SusceptibleGenotypeGenotype
Benzene, 100 ppm – Bone Marrow %MN-RET Chr 10 QTL
Benzene, 100 ppm – Bone Marrow %MN-RET
Chr 2:136-144MB
QTL segment
C ff fCoefficient for allele identity
LOD
Benzene, 100 ppm – Bone Marrow %MN-RET Chr 2 QTL
Chr 2:136 -144 Mb
Benzene 100 ppm – Bone Marrow %MN-RETChr 10:27-35Mb Chr 2:136 -144 Mb
MGI Data set 11:UNC MUGA
Nkain2
Data set 11:UNC-MUGA
Tasp1_RPTPk_Flrt3_bCat_FGFR1_BZ100ppm_QTLsp53_Trdn_Tasp1_cRaf_AKT1_BZ100ppm QTLs
p = 2.2 x 10-07
Nkain2p = 7.1 x 10-05
Nkain2Sult3aMacrod2
p = 2.45 x 10-07
CyclinD1_C20orf7_ABTAP_UBL7_BZ_100ppm QTLs
Conclusions• Population based models required to determine inter• Population based models required to determine inter-
individual variability in response to toxic exposures (J:DO)• Benzene – ADME/TK (heritable quantitative trait)• Benzene – DNA damage (heritable quantitative trait)• Benzene – BMD/RfC and uncertainty factors/defaults• Discovery statistical analysis of genotype phenotype• Discovery - statistical analysis of genotype-phenotype
relationships and candidates for causal mechanisms• Validation – hypothesis based research for confirmation
f l l ti hi i CC AIL i i d i itof causal relationships using CC AILs in vivo and in vitro reverse genetics
AcknowledgementsUniversity of Arizona (ADME)• Gabe Knudsen - ADME
NTP/NIEHS (ADME & Toxicity)• Dan Morgan – Inhalation toxicology• Gabe Knudsen - ADME
• Glenn Sipes - ADME• Bob Kuester – ADME
• Dan Morgan – Inhalation toxicology• Grace Kissling - Biostatistics• Debra King - Hematology
ILS-Inc. (Genetic Toxicology)• Kim Shepard• Cheryl Hobbs
• Kristine Witt – Genetic Toxicology• Keith Shockley – Bioinformatics• Mike Cunningham – ADME
• Les RecioThe Jackson Laboratory (Genetics)• Dan Gatti (Systems Genetics)
Alion ( Animal Care & Exposures)• Herman Price• Bob O’Connor ( y )
• Gary Churchill (Systems Genetics)UNC-CH (Genetics)• David Threadgill (NCSU)
• Bob O Connor• Norm Gage
David Threadgill (NCSU)• Fernando Pardo-Manuel de Villena
Questions/DiscussionQuestions/Discussion